The Pharmacy and Poisons Board (PPB) has ordered the quarantine of pain killer drug Mefnac oral (Mefenamic Acid 50 Mg/5 MI).
In a statement on Wednesday, December 11, PPB stated that the action has been taken due to suspected contamination with Diethylene Glycol (DEG)/Ethylene Glycol (EG) at levels above acceptable limits.
“The Pharmacy and Poisons Board (“the Board”) informs the public of a Quarantine Order issued for Mefnac Oral Suspension (Mefenamic Acid 50 Mg/5 MI) Manufactured by Efroze Chemical Industries Pvt Ltd, Pakistan,” PPB said.
In light of this, the Board advised all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately quarantine the product.
They were also directed to stop the further distribution, sale, issuance, or use until further communication from the Board.
“The Board encourages the public to report any suspected cases of sub-standard medicines or adverse drug reactions to the nearest healthcare facility or the Pharmacy and Poisons Board,’ the statement read further.
At the same time board, warned of an unregistered and substandard product, Floracil 1000 (Fluorouracil 1000mg/2ml) Injection, manufactured by Bruck Pharma PVT LTD, India.
Also Read: Govt Orders Quarantine of Popular Cancer Drug
Consequently, PPB strongly cautioned the public and healthcare professionals against the trade, distribution, wholesale, retail, issuance, dispensing, use, or administration to patients of this product
“Pharmacy and Poisons Act, (CAP 244), monitors the market for the presence of illegal Health Products and Technologies (HPTs). During routine post-market surveillance (PMS) activities, the Board identified an unregistered and substandard product, Floracil 1000 (Fluorouracil 1000mg/2ml) Injection, manufactured by Bruck Pharma PVT LTD, India,” read the statement in part.
ADVERT
Further, in collaboration with Government Investigative Agencies, the Board said it will take legal and regulatory action against any individuals involved in placing this unregistered product in the market, in violation of the Pharmacy and Poisons Act (CAP 244).
“The Board remains committed to protecting public health and urges the public and healthcare professionals to remain vigilant,” PPB affirmed.
Also Read: Govt Recalls Drug Over Labelling Mix-Ups
Popular Cancer Drug Flurasted 500 Recalled
The orders come in less than a week recalled a popular cancer drug named Flurasted 500 (5-Fluorouracil) Injection Batch no. HHP24017.
PPB in a statement on Thursday, December 5, stated that the quarantine order is being issued due to a market complaint on the appearance parameter of the content.
The board directed all pharmaceutical outlets, healthcare facilities, professionals, and members of the public to immediately stop the further distribution, sale, issuance, or use of the affected product batch.
“The Pharmacy and Poisons Board (“the Board”) orders the quarantine of Flurasted 500 (5-Fluorouracil) Injection Batch no. HHP24017 Manufactured by Halsted Pharma Private Limited, India,” PPB said.
Follow our WhatsApp Channel and join our WhatsApp Group for real-time news updates.
